Compare LCTX & AVNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LCTX | AVNW |
|---|---|---|
| Founded | 1990 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 251.4M | 255.9M |
| IPO Year | 1996 | 2007 |
| Metric | LCTX | AVNW |
|---|---|---|
| Price | $0.79 | $15.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | $5.50 | ★ $32.38 |
| AVG Volume (30 Days) | ★ 2.1M | 168.0K |
| Earning Date | 11-12-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 90.00 |
| EPS | ★ N/A | N/A |
| Revenue | $14,556,000.00 | ★ $243,858,000.00 |
| Revenue This Year | $4.38 | $5.07 |
| Revenue Next Year | $10.80 | $5.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 53.24 | 0.56 |
| 52 Week Low | $0.77 | $13.92 |
| 52 Week High | $1.99 | $27.02 |
| Indicator | LCTX | AVNW |
|---|---|---|
| Relative Strength Index (RSI) | 34.81 | 35.70 |
| Support Level | N/A | $14.70 |
| Resistance Level | $1.16 | $20.66 |
| Average True Range (ATR) | 0.08 | 1.27 |
| MACD | -0.03 | -0.19 |
| Stochastic Oscillator | 2.86 | 8.30 |
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.
Aviat Networks Inc manufacture and sell a range of wireless transport and access networking products, solutions and services to two principal customer types. Communications Service Providers (CSPs): These include mobile and fixed telecommunications network operators, broadband and internet service providers and network operators which generate revenues from the communications services. Private network operators: These are customers which do not resell communications services but build networks for reasons of economics, autonomy, and/or security to support a wide variety of mission critical performance applications. Examples include federal, state and local government agencies, transportation agencies, energy and utility companies, public safety agencies and broadcast network operators.